Credit: Media Relations
Researchers found that synthetic cannabidiol (CBD) augments the anti-viral response of cells to three key proteins produced by the SARS-CoV-2 genome – which was, until now, an unknown effect…
Credit: Audrey Carleton
Cannabidiol—the non-psychoactive cannabis compound better known as CBD—is a potent blocker of SARS-CoV-2 replication in human cells, new research shows. Not only that, but a survey of real-world patients taking prescribed CBD found a “significant” negative relationship between CBD consumption and COVID-19 infection.
Credit: David Correa
According to the report by Allied Market Research, titled, “CBD Hemp Oil Market By Product (Organic source, Inorganic source), and Application (Diabetes, Neurological disorders, Mood disorders, Pain relief, Others): Global Opportunity Analysis and Industry Forecast, 2020-2027”. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.